Nathan D. Jorgensen - Sep 1, 2022 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Signature
/s/ Rich Segal, Attorney-in-Fact
Stock symbol
VOR
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
4
Date filed
9/6/2022, 04:14 PM
Previous filing
Feb 3, 2022
Next filing
Feb 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Award $0 +86K +293.83% $0.00 115K Sep 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Employee Stock Option (right to buy) Award $0 +86K $0.00 86K Sep 1, 2022 Common Stock 86K $5.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in four equal installments on each of March 1, 2023, September 1, 2023, March 1, 2024 and September 1, 2024, in each case, subject to the Reporting Person's continued service as of each such date.
F2 The shares shall vest and become exercisable in a series of 24 successive equal monthly installments beginning on October 1, 2022, in each case subject to the Reporting Person's continued service as of each such date.